在结核病患者中测量异化,使用指汗与肌素正常化:一项受控剂量研究
K Longman1, O W Akkerman2, S Ghimire3
1School of Chemistry and Chemical Engineering, University of Surrey, Guildford, United Kingdom.
International journal of antimicrobial agents
|June 25, 2024
概括
指汗检测提供了一种方便的方法来监测结核病 (TB) 药物坚持和治疗药物监测 (TDM). 这种非侵入性方法可以准确检测异化水平,有助于治疗成功.
科学领域:
- 药理动力学 药理动力学
- 分析化学 分析化学
- 临床诊断 临床诊断 临床诊断
背景情况:
- 对抗结核病 (TB) 药物的不良坚持有助于治疗失败和耐药性.
- 使用血液或唾液的治疗药物监测 (TDM) 有助于评估坚持性和剂量调整.
- 指汗检测为患者监测提供了一个非侵入性的替代方案.
研究的目的:
- 为了评估手指汗水测试的可行性,以检测药物坚持.
- 评估手指汗液分析作为TDM的半定量工具.
- 建立一种用于监测抗结核病药物水平的新方法.
主要方法:
- 十名患者接受了受控剂量的异化.
- 用手指的汗水,血液和唾液样本在药物注射后被采集.
- 液体染色学-质谱学用于样本分析.
主要成果:
- 在服用后1-6小时内,可以在指汗液中检测到异化物.
- 在汗水中将异化物正常化为肌氨酸,改善了与血清度的相关性.
- 这种规范化方法可以考虑样本体积的变化.
结论:
- 这项研究表明,在指汗中测量了异化的时间流程,与血液水平相关.
- 指汗中的药物与肌素的比率提供了一个可行的TDM方法.
- 这种可适应的技术可以提高患者体验,减少临床工作量.
更多相关视频
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
2.2K
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
8.6K
相关概念视频
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis V
177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Pulmonary Tuberculosis III
321
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
321
